Recent Progress in the Molecular Recognition and Therapeutic Importance of Interleukin-1 Receptor-Associated Kinase 4-Reference-Cited by-同舟云学术

Recent Progress in the Molecular Recognition and Therapeutic Importance of Interleukin-1 Receptor-Associated Kinase 4

Published:2016-11-13 Issue:11 Volume:21 Page:1529
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Patra Mahesh,Choi Sangdun

Funder

National Research Foundation of Korea

Korea Health Industry Development Institute

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/21/11/1529/pdf

Reference70 articles.

1. The Protein Kinase Complement of the Human Genome

2. IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase

3. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

4. Genetic variation in Toll-like receptors and disease susceptibility

5. Structural Insights into the Assembly of Large Oligomeric Signalosomes in the Toll-Like Receptor–Interleukin-1 Receptor Superfamily

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer;Acta Pharmaceutica Sinica B;2024-09

2. Discovery of KT-474─a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases;Journal of Medicinal Chemistry;2024-08-16

3. Fragment-Based Anti-inflammatory Agent Design and Target Identification: Discovery of AF-45 as an IRAK4 Inhibitor to Treat Ulcerative Colitis and Acute Lung Injury;Journal of Medicinal Chemistry;2024-06-24

4. Both IRAK3 and IRAK1 Activate the MyD88–TRAF6 Pathway in Zebrafish;The Journal of Immunology;2024-06-07

5. Metadichol® induced expression of the TLR family of receptors in PBMCs;2024-04-07